Sean Ekins received his M.Sc., Ph.D., and D.Sc. from the University of Aberdeen. His areas of interest are in vitro and computational ADME/Tox, biomarkers, systems biology, and computational drug discovery. Dr. Ekins was a postdoctoral fellow at Lilly Research Laboratories in the drug disposition group and has worked as a senior scientist at Pfizer and Lilly Research Laboratories in drug-drug interaction screening and computational ADME/Tox groups, respectively. Dr. Ekins was also Associate Director of Computational Drug Discovery at Concurrent Pharmaceuticals, Inc. and Vice President of Computational Biology at GeneGo.
Dr. Ekins is currently Principal Consultant for Collaborations in Chemistry and Collaborations; Director at Collaborative Drug Discovery Inc; Senior Vice President of Computational Biology at Arnold Consultancy and Technology LLC; Adjunct Associate Professor, School of Pharmacy Department of Pharmaceutical Sciences, University of Maryland; and Adjunct Professor in the Department of Pharmacology at University of Medicine and Dentistry of New Jersey—Robert Wood Johnson Medical School, Piscataway, NJ.